Literature DB >> 1736312

J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5.

T D Randall1, R M Parkhouse, R B Corley.   

Abstract

Two functional polymeric forms of IgM can be produced by antibody-secreting B cells. Hexameric IgM lacks detectable J (joining) chain and activates complement 17-fold better than pentameric IgM, which usually contains one J chain per pentamer. Using the inducible B-cell lymphoma CH12, we determined if the synthesis of a particular polymeric form of IgM is a fixed property of B cells or can be altered. Lipopolysaccharide (LPS)-stimulated CH12 cells produced mixtures of IgM hexamers and pentamers, resulting in antibody with high complement-fixing activity. In contrast, interleukin-5-stimulated CH12 cells secreted predominantly pentameric IgM, with a correspondingly lower lytic activity. Differences in lytic activity were due only to the amount of hexameric IgM in the secreted antibody. Interleukin 5 stimulated higher production of J chain RNA and protein than LPS, while LPS induced the highest levels of the secretory form of mu protein. The amount of hexameric IgM secreted was therefore inversely proportional to the level of intracellular J chain protein in the responding B cells. We conclude that the biologic function of IgM produced by B cells differs depending on how they are stimulated and that this difference may be regulated by the relative availabilities of J chain and secretory mu proteins during IgM polymerization.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736312      PMCID: PMC48365          DOI: 10.1073/pnas.89.3.962

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  A model system for peptide hormone action in differentiation: interleukin 2 induces a B lymphoma to transcribe the J chain gene.

Authors:  M A Blackman; M A Tigges; M E Minie; M E Koshland
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

Review 2.  The coming of age of the immunoglobulin J chain.

Authors:  M E Koshland
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

3.  Carrier-specific T cells sufficient for the expression of multiple isotypes in B cell cultures.

Authors:  D B Kotloff; I M Zitron; J J Cebra
Journal:  Eur J Immunol       Date:  1987-01       Impact factor: 5.532

4.  Electron microscopic studies of mouse immunoglobulin M; structure and reconstitution following reduction.

Authors:  R M Parkhouse; B A Askonas; R R Dourmashkin
Journal:  Immunology       Date:  1970-04       Impact factor: 7.397

5.  J chain deficiency in human IgM monoclonal antibodies produced by Epstein-Barr virus-transformed B lymphocytes.

Authors:  Y G Meng; A B Criss; K E Georgiadis
Journal:  Eur J Immunol       Date:  1990-11       Impact factor: 5.532

6.  Molecular events during B lymphocyte differentiation. Induction of endogenous mouse mammary tumor proviral envelope transcripts after B cell stimulation.

Authors:  S Sharma; L B King; R B Corley
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

7.  Diversity in the available repertoire of murine antibodies reactive with bromelain-treated isologous erythrocytes.

Authors:  J D Conger; H J Sage; R B Corley
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

8.  On the structure of polymeric IgM.

Authors:  A C Davis; K H Roux; M J Shulman
Journal:  Eur J Immunol       Date:  1988-07       Impact factor: 5.532

9.  Polymeric immunoglobulin M is secreted by transfectants of non-lymphoid cells in the absence of immunoglobulin J chain.

Authors:  A Cattaneo; M S Neuberger
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

10.  Intermolecular disulfide bonding in IgM: effects of replacing cysteine residues in the mu heavy chain.

Authors:  A C Davis; K H Roux; J Pursey; M J Shulman
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  19 in total

1.  Improved antibody production in Chinese hamster ovary cells by ATF4 overexpression.

Authors:  Ahmad M Haredy; Akitoshi Nishizawa; Kohsuke Honda; Tomoshi Ohya; Hisao Ohtake; Takeshi Omasa
Journal:  Cytotechnology       Date:  2013-09-13       Impact factor: 2.058

2.  Transgenic mice secreting coronavirus neutralizing antibodies into the milk.

Authors:  I Sola; J Castilla; B Pintado; J M Sánchez-Morgado; C B Whitelaw; A J Clark; L Enjuanes
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Antigenic specificity and expression of a natural idiotope on human pentameric and hexameric IgM polymers.

Authors:  Vladimir Petrušić; Irena Zivković; Marijana Stojanović; Ivana Stojićević; Emilija Marinković; Aleksandra Inić-Kanada; Ljiljana Dimitijević
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

4.  Structural correlates of mouse IgA allotypes.

Authors:  Julia M Phillips-Quagliata
Journal:  Immunogenetics       Date:  2009-12-15       Impact factor: 2.846

5.  Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation.

Authors:  T D Randall; F E Lund; J W Brewer; C Aldridge; R Wall; R B Corley
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

6.  Roles of heavy and light chains in IgM polymerization.

Authors:  K D Bornemann; J W Brewer; G B Beck-Engeser; R B Corley; I G Haas; H M Jäck
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

7.  Site-Specific N-Glycosylation of Recombinant Pentameric and Hexameric Human IgM.

Authors:  Edward S X Moh; Chi-Hung Lin; Morten Thaysen-Andersen; Nicolle H Packer
Journal:  J Am Soc Mass Spectrom       Date:  2016-04-01       Impact factor: 3.109

Review 8.  Complement inhibitors to treat IgM-mediated autoimmune hemolysis.

Authors:  Diana Wouters; Sacha Zeerleder
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

9.  Engineering of chaperone systems and of the unfolded protein response.

Authors:  Saeed U Khan; Martin Schröder
Journal:  Cytotechnology       Date:  2008-08-15       Impact factor: 2.058

10.  The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78.

Authors:  Leo Rasche; Johannes Duell; Charlotte Morgner; Manik Chatterjee; Frank Hensel; Andreas Rosenwald; Hermann Einsele; Max S Topp; Stephanie Brändlein
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.